This inventor holds 1 USPTO granted patent. Top assignee: Riken Corporation. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Innovations of Takeshi Nara in Therapeutic Agents
Introduction
Takeshi Nara is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of therapeutic agents, particularly in the treatment of diseases associated with parasites. His innovative approach utilizes mechanisms that differ from conventional technologies, showcasing his commitment to advancing medical science.
Latest Patents
Takeshi Nara holds 1 patent for a therapeutic agent designed to treat a disease associated with parasites. This patent includes a method for preventing infections by parasites or killing them, employing a unique mechanism that sets it apart from existing solutions. The therapeutic agent comprises an antisense oligonucleotide that suppresses the expression of an inositol 1,4,5-trisphosphate receptor protein in parasites, highlighting his innovative approach to tackling parasitic infections.
Career Highlights
Nara is affiliated with Riken Corporation, a leading research institution in Japan. His work at Riken has allowed him to focus on groundbreaking research and development in the field of therapeutic agents. His dedication to innovation has positioned him as a key figure in the scientific community.
Collaborations
Throughout his career, Takeshi Nara has collaborated with esteemed colleagues, including Katsuhiko Mikoshiba and Muneaki Hashimoto. These collaborations have further enriched his research and contributed to the advancement of therapeutic technologies.
Conclusion
Takeshi Nara's contributions to the field of therapeutic agents demonstrate his innovative spirit and commitment to improving health outcomes. His work continues to inspire advancements in medical science and offers hope for effective treatments against parasitic diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
